Method Article

Engineered Vascularized Muscle Flap

DOI:

10.3791/52984

⸱

January 11th, 2016

* These authors contributed equally

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

To date, thick tissue defects are typically reconstructed by applying autologous tissue flaps or engineered tissues. In this protocol, we present a new method for engineering vascularized tissue flap bearing an autologous pedicle, to serve as a substitute to autologous flaps.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

One of the main factors limiting the thickness of a tissue construct and its consequential viability and applicability in vivo, is the control of oxygen supply to the cell microenvironment, as passive diffusion is limited to a very thin layer. Although various materials have been described to restore the integrity of full-thickness defects of the abdominal wall, no material has yet proved to be optimal, due to low graft vascularization, tissue rejection, infection, or inadequate mechanical properties. This protocol describes a means of engineering a fully vascularized flap, with a thickness relevant for muscle tissue reconstruction. Cell-embedded poly L-lactic acid/poly lactic-co-glycolic acid constructs are implanted around the mouse femoral artery and vein and maintained in vivo for a period of one or two weeks. The vascularized graft is then transferred as a flap towards a full thickness defect made in the abdomen. This technique replaces the need for autologous tissue sacrifications and may enable the use of in vitro engineered vascularized flaps in many surgical applications.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Abdominal wall defects often arise following severe trauma, cancer treatment, burns and removal of infected mesh. These defects often involve significant tissue loss, requiring complicated surgical procedures and presenting a major challenge for plastic reconstruction surgeons 1-4. Tissue engineering researchers seeking new sources for artificial tissues have explored different materials, cell sources and growth factors. Successful restorations of various tissues, such as trachea 5,6, bladder 7, cornea 8, bone 9and skin 10, by implantation of engineered tissues were previously reported. However, fabrica....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

All animal studies were approved by the Committee of the Ethics of Animal Experiments of the Technion. For this procedure, athymic nude mice were used to avoid immunological rejection. If using another type of mouse, the mice should be shaved prior to the surgical procedure and administration of cyclosporine (or another anti-rejection substitute) is recommended.

1. Scaffold Preparation and Cell Embedding

  1. Prepare scaffolds composed of 1:1 mixture of poly-L-lactic-acid (PLLA) and polylactic-co-glycolic-acid (PLGA), in the following manner:
    1. Dissolve 500 mg of PLLA and 500 mg of PLGA in 10 ml chloroform.
    2. Add 0....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Graft vascularization and perfusion in vivo

The grafts were implanted one or two weeks prior to their transfer as axial flaps. At one and two weeks post-implantation, gross observation of the graft area revealed viable and vascularized tissue grafts. These grafts proved to be highly vascularized, as determined by positive CD31 immunostaining (Figure 1A), and highly perfused, as evidenced by FITC-dextran tail vein injection and ultrasound measurements. Many vessels wer.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The advances in tissue engineering have been met with a growing demand for substitute tissues for reconstruction of various tissue types. A variety of synthetic 1,17,18 and biological 14-16 materials as well as fabrication methods have been assessed for their capacity to address these demands. However, despite the progress in clinical care and in tissue engineering, the restoration of full-thickness abdominal wall defects remains a challenge. A tissue adequate for reconstruction of such massive defe.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors declare that they have no competing financial interests.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This research was supported by the FP7 European Research Council Grant 281501, ENGVASC.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
small fine straight scissorsFine Science Tools (FST)14090-09
spring scissorsFine Science Tools (FST)15003-08
straight forceps with fine tipFine Science Tools (FST)11251-20
serrated forceps Fine Science Tools (FST)11050-10
needle holderFine Science Tools (FST)12500-12
Small vessel cauterizer Fine Science Tools (FST)18000-00
DuratearsAlcon5686
SedaxylanEuravetDJ03
Clorketam 1000Vetoquinol4A0726B
BuprenorphinevetmarketB15100
4-0 silk suturesAssut sutures647
6-0 polypropylene suturesAssut sutures9351F
8-0 silk suturesAssut sutures684568
Insulin syringe (6 mm needle)BD324911
Vevo 2100 high-resolution ultrasound systemVisualSonics inc.
MS250 non-linear transducerVisualSonics inc.
Micromarker non-targeted contrast agentVisualSonics inc.VS-11694
tail vein catheterVisualSonics inc.VS-11912
Vevo 2100 softwareVisualSonics inc.
fluorescein isothiocyanate-conjugated dextranSigmaFD500S
MatlabMathworks, MA, USA
KimwipesKimtech34120
antigen unmasking solutionVector laboratoriesH-3300
anti-CD31 antibodyAbcam ab28364
biotinylated goat anti-rabbit (secondary) antibodyVector laboratoriesBA-1000
streptavidin-peroxidaseJackson 016-030-084
Mayer's hamatoxylin solutionSigma-AldrichMHS-16
aminoethylcarbazole (AEC) substrate kitLife technologies, Invitrogen 00-2007
VectamountVector laboratoriesH-5501

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Engelsman, A. F., van der Mei, H. C., Ploeg, R. J., Busscher, H. J. The phenomenon of infection with abdominal wall reconstruction. Biomaterials. 28 (14), 2314-2327 (2007).
  2. De Coppi, P., et al. Myoblast-acellular ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Vascularized Muscle FlapTissue EngineeringBiodegradable ScaffoldCell SeedingIn Vitro CultureFemoral Artery ImplantationAnastomosis With Host VesselsPedicled Flap TransferAbdominal Wall ReconstructionUltrasound Imaging

Related Articles